NeurogesX Reports Successful Phase III Trial For NGX-4010 In Post-Herpetic Neuralgia
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm plans to file with EMEA for peripheral neuropathic pain indication later this year.